Rezolute (RZLT) Return on Capital Employed Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -890.00 |
| Dec 31, 2025 | 3,037.00 |
| Sep 30, 2025 | 25,002.00 |
| Jun 30, 2025 | 14,876.00 |
| Mar 31, 2025 | 5,981.00 |
| Dec 31, 2024 | 10,971.00 |
| Sep 30, 2024 | 14,613.00 |
| Jun 30, 2024 | 40,352.00 |
| Mar 31, 2024 | 247,987.00 |
| Dec 31, 2023 | -105,603.00 |
| Sep 30, 2023 | -49,812.00 |
| Jun 30, 2023 | -122,974.00 |
| Mar 31, 2023 | 169,937.00 |
| Dec 31, 2022 | 38,278.00 |
| Sep 30, 2022 | 24,320.00 |
| Jun 30, 2022 | 18,877.00 |
| Mar 31, 2022 | 16,482.00 |
| Dec 31, 2021 | 13,736.00 |
| Sep 30, 2021 | 10,141.00 |
| Jun 30, 2021 | 12,026.00 |
| Mar 31, 2021 | 16,576.00 |
| Dec 31, 2020 | 10,564.00 |
| Sep 30, 2020 | -16,034.00 |
| Jun 30, 2020 | -10,613.00 |
| Mar 31, 2020 | -4,037.00 |
| Dec 31, 2019 | -2,910.00 |
| Sep 30, 2019 | -9,272.00 |
| Jun 30, 2019 | -38,537.00 |
| Mar 31, 2019 | -225,551.00 |
| Dec 31, 2018 | 86,585.00 |
| Sep 30, 2018 | 30,912.00 |
| Jun 30, 2018 | 102,900.00 |